
EntreMed is a clinical-stage pharmaceutical
company focused on developing multi-mechanism
drugs that target disease cells and the blood vessels
that nourish them. Working directly with their communications team, we built the site around
three distinct audiences—patients in clinical trials,
investors, and scientists. It’s almost like having three websites in one. We lead the creative for redesigning
other elements of the company’s new, unified
corporate image, all aimed at taking complex
materials and simplifying them.